SCHOTT Pharma AG & Co. KGaA Analysts' estimates >> Group and Segments
Consensus as of: 2024-03-27

KPI[EUR m]FY 2023FY 2024 EFY 2025 EFY 2026 E
Revenue Number of Estimates10108
Revenue Highest996.01,177.21,341.0
Revenue Average982.41,148.51,297.6
Revenue Consensus (Median)898.6981.31,147.01,304.5
Revenue Lowest964.01,119.51,264.8
Organic revenue growth (in %)Number of Estimates553
Organic revenue growth (in %)Highest9.518.314.3
Organic revenue growth (in %)Average9.116.513.1
Organic revenue growth (in %)Consensus (Median)8.09.017.213.0
Organic revenue growth (in %)Lowest8.814.112.0
EBITDANumber of Estimates10108
EBITDAHighest269.0350.0413.0
EBITDAAverage264.0331.0394.5
EBITDAConsensus (Median)239.0264.0331.2397.2
EBITDALowest258.9316.6376.1
EBITDA Margin (in %)Number of Estimates10108
EBITDA Margin (in %)Highest27.229.831.8
EBITDA Margin (in %)Average26.928.830.4
EBITDA Margin (in %)Consensus (Median)26.626.928.830.3
EBITDA Margin (in %)Lowest26.627.729.1
EBIT Number of Estimates10108
EBIT Highest208.0258.0315.0
EBIT Average200.0247.0299.2
EBIT Consensus (Median)192.4199.7246.1299.8
EBIT Lowest191.8239.0282.5
Net incomeNumber of Estimates10108
Net incomeHighest158.0200.0248.0
Net incomeAverage151.5188.7230.8
Net incomeConsensus (Median)151.8150.8188.1231.6
Net incomeLowest146.9176.6216.0
EPSNumber of Estimates10108
EPSHighest1.051.331.65
EPSAverage1.011.251.53
EPSConsensus (Median)1.011.001.251.54
EPSLowest0.981.171.43
DPSNumber of Estimates997
DPSHighest0.160.220.29
DPSAverage0.150.190.24
DPSConsensus (Median)0.150.150.190.24
DPSLowest0.150.180.22
CapexNumber of Estimates997
CapexHighest-207.0-183.0-164.8
CapexAverage-220.4-204.1-184.6
CapexConsensus (Median)-175.5-220.0-200.0-183.0
CapexLowest-229.8-247.5-216.0
FCFNumber of Estimates997
FCFHighest14.783.7126.5
FCFAverage-6.631.496.9
FCFConsensus (Median)10.2-7.029.0105.0
FCFLowest-31.7-27.725.0
DCS, RevenueNumber of Estimates885
DCS, RevenueHighest590.4690.3765.8
DCS, RevenueAverage569.5622.3668.1
DCS, RevenueConsensus (Median)558.0568.1611.4669.6
DCS, RevenueLowest547.3569.2586.3
DCS, EBITDANumber of Estimates884
DCS, EBITDAHighest132.0165.7183.4
DCS, EBITDAAverage118.4140.9159.4
DCS, EBITDAConsensus (Median)109.5115.0138.0162.5
DCS, EBITDALowest111.7122.5129.1
DCS, EBITDA Margin (in %)Number of Estimates884
DCS, EBITDA Margin (in %)Highest22.525.225.7
DCS, EBITDA Margin (in %)Average20.822.623.8
DCS, EBITDA Margin (in %)Consensus (Median)19.620.622.223.7
DCS, EBITDA Margin (in %)Lowest19.621.022.0
DDS, RevenueNumber of Estimates885
DDS, RevenueHighest426.0575.1718.9
DDS, RevenueAverage410.7521.4621.6
DDS, RevenueConsensus (Median)343.6410.7541.0628.0
DDS, RevenueLowest393.6441.3499.0
DDS, EBITDANumber of Estimates884
DDS, EBITDAHighest156.2205.0262.0
DDS, EBITDAAverage148.4192.6237.9
DDS, EBITDAConsensus (Median)128.8149.3199.2246.4
DDS, EBITDALowest135.8165.3196.6
DDS, EBITDA Margin (in %)Number of Estimates884
DDS, EBITDA Margin (in %)Highest37.938.339.5
DDS, EBITDA Margin (in %)Average36.137.038.0
DDS, EBITDA Margin (in %)Consensus (Median)37.536.037.238.3
DDS, EBITDA Margin (in %)Lowest34.535.036.0
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.